Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112372
Status:
COMPLETED
Last Update Posted:
2015-02-12
First Post:
2005-06-02
Brief Title:
Study of Oral Ridaforolimus AP23573 MK-8669 to Treat Patients With Refractory or Advanced Malignancies MK-8669-016 AM4COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC